Investing

Axsome Therapeutics : AXSM

AXSM

Stock Data

$206.53

$1.22 (0.59%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Axsome Therapeutics Inc is a New York-based biopharmaceutical company focused on developing innovative treatments for central nervous system disorders. Its product lineup includes Auvelity for major depressive disorder and Sunosi for narcolepsy or obstructive sleep apnea-related daytime sleepiness. The company is also advancing several drugs through clinical trials, targeting conditions like Alzheimer's disease agitation, migraine, narcolepsy, fibromyalgia, and more. Axsome's commitment to addressing unmet medical needs in mental health and neurological conditions underscores its research-driven approach.

All Axsome Therapeutics Articles

1 Article

Ian Cooper | Dec 31, 2025 at 10:08 AM EST

Market Movers: Nike Exploding Higher on Insider Buying

Oversold shares of Nike (NYSE: NKE | NKE Price Prediction) are on the run. All on news that CEO Elliott…